Quantcast

Latest Halozyme Therapeutics Inc. Stories

2015-01-21 08:28:36

SAN DIEGO, Jan. 21, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today announced the appointment of Jean-Pierre Bizzari, M.D. to its Board of Directors. Dr.

2015-01-12 08:31:20

- Evaluating and advancing investigational PEGPH20 in two cancer settings associated with low survival - SAN DIEGO, Jan. 12, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-01-07 08:30:16

- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - SAN DIEGO, Jan.

2015-01-06 16:27:16

SAN DIEGO, Jan. 6, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the 33rd Annual J.P.

2015-01-05 08:31:20

SAN DIEGO, Jan. 5, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2014-12-30 08:24:47

SAN DIEGO, Dec. 30, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2014-12-19 08:25:09

SAN DIEGO, Dec. 19, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2014-12-12 08:25:05

SAN DIEGO, Dec. 12, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2014-11-25 16:28:19

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Halozyme Therapeutics, Inc.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related